CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
Author
A Ashkenazi
A Thorburn
+45Â more
A Younes
AW Tolcher
C Schulz
C-H Köhne
CH Mom
DM Heijink
E Mori
E Oikonomou
EM Janssen
F Toscano
FA Greco
G Gallant
GJ Ullenhag
H Hurwitz
H Schulze-Bergkamen
HA Elrod
J Gong
J Kouhara
JA Meyerhardt
JW Yu
K Connolly
KY Chung
L Pukac
M Moehler
M Niyazi
M Parkin
M Przyborek
NK Clemo
P Korkolopoulou
P Thérasse
RC Humphreys
RM Goldberg
RW Johnstone
S Huerta
S Kanzler
S Leong
SJ Hotte
SJ Zheng
T Trarbach
TR Wilson
TR Wilson
V Granci
V Heinemann
V Sneller
XM Yin
Publication venue
Nature Publishing Group
Publication date
Field of study
Get PDF
Crossref
PubMed Central
Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy
Author
A Collier
AJ Augustin
+24Â more
AJ Augustin
BR Lucchesi
DN Granger
F Simonelli
GR Schacterle
GYN Iyer
H Esterbauer
H Ohkawa
IM Goldstein
J Jos
J Thérasse
JA Sbarra
JI Gross
JR Hartmann
M Doly
M Weller
M Weller
M Weller
MA Gimbrone
OD Saugstad
P Borgeat
PE Jennings
PP Bradley
SK Srivastava
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref